Ligand validation:3PXO

RET: RETINAL

RET is a Ligand Of Interest in 3PXO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PXO_RET_A_801	30%	41%	0.3	0.968	1.29	1.01	3	2	0	0	100%	0.9524
7ZBC_RET_B_402	96%	56%	0.064	0.97	0.92	0.8	2	1	0	0	100%	0.9524
2HPY_RET_B_1296	81%	11%	0.116	0.969	2.3	1.9	4	6	1	0	100%	0.381
8A6D_RET_A_402	80%	17%	0.083	0.932	2.34	1.3	5	2	0	0	100%	0.9524
7ZBE_RET_B_402	79%	52%	0.103	0.947	1.05	0.82	2	1	0	0	100%	0.9524
5DYS_RET_A_401	67%	39%	0.164	0.973	0.96	1.42	1	6	0	0	100%	0.9524
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
5G28_RET_A_1268	97%	23%	0.051	0.968	1.29	1.84	3	5	0	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.